Equillium Inc reports results for the quarter ended in June - Earnings Summary

Equillium

08/08/2024 22:21

* Equillium Inc  EQ.OQ  reported quarterly adjusted earnings
of 1
cent​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -10
cents.  The mean expectation of four analysts for the quarter
was for a loss of 15 cents per share. Wall Street expected
results to range from -22 cents to -8 cents per share.
    * Revenue rose 51.8% to $13.85 million from a year ago;
analysts
expected $6.33 million. 
    * Equillium Inc's reported EPS for the quarter was 1 cent​.
    * The company reported quarterly net income of $468
thousand.
    * Equillium Inc shares had risen by 5.9% this quarter and
gained 1.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 9.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is  "buy."

Wall Street's median 12-month price target for Equillium Inc is
$7.00 
This summary was machine generated from LSEG data August 8 at
09:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.15          0.01           Beat
 Mar. 31 2024      -0.15          -0.08          Beat
 Dec. 31 2023      -0.17          -0.07          Beat
 Sep. 30 2023      -0.17          -0.11          Beat